CompletedNot Applicable

Treatment Time-frame Guideline for Dry Needling in the Lower Limb

Ireland28 participantsStarted 2019-09-16

Plain-language summary

This study evaluates the impact of treating myofascial trigger points with a single session of dry needling on maximal isometric strength in the short term. Two groups will receive dry needling in separate muscle groups and a third group will receive no dry needling.

Who can participate

Age range

18 Years – 30 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Must have latent trigger points in their rectus femoris and gluteus maximus Exclusion Criteria: * Active trigger points in rectus femoris or gluteus maximus * Participants with current injuries * History of fibromyalgia or myofascial pain syndrome * History of blood disorder which prevents dry needling * Needle phobia * History of surgery in the last 6 months

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Isometric peak force during the isometric mid-thigh pull

Timeframe: Baseline, 24 hours post intervention, 48 hours post intervention, 72 hours post intervention.

Isometric peak rate of force development during the isometric mid-thigh pull

Timeframe: Baseline, 24 hours post intervention, 48 hours post intervention, 72 hours post intervention.

Relative isometric peak force during the isometric mid-thigh pull

Timeframe: Baseline, 24 hours post intervention, 48 hours post intervention, 72 hours post intervention.

Relative isometric peak rate of force development during the isometric mid-thigh pull

Timeframe: Baseline, 24 hours post intervention, 48 hours post intervention, 72 hours post intervention.

Normalised isometric peak rate of force development during the isometric mid-thigh pull

Timeframe: Baseline, 24 hours post intervention, 48 hours post intervention, 72 hours post intervention.

Isometric time interval rate of force development during the isometric mid-thigh pull

Timeframe: Baseline, 24 hours post intervention, 48 hours post intervention, 72 hours post intervention.

Trial details

NCT IDNCT04161105

SponsorSouth East Technological University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-11-29

View on ClinicalTrials.gov More Trigger Points trials